Early trial results for Alzheimer’s ‘medical food’
A new trial published in Alzheimer’s and Dementia shows that Souvenaid, a multinutrient drink, could improve memory in patients with mild Alzheimer’s.
Posted on 7th January 2010
Other measures of the disease did not improve over the 12 week study, but the results show that further clinical trials are needed.
The researchers studied 225 people with mild Alzheimer’s. Half the participant took the ‘medical food’ drink, and half a ‘control’ drink. After 12 weeks the group taking the medical food had improved on a verbal memory test compared to those taking the control drink. Other measures of Alzheimer’s, including a standard measure of the disease and tests of activities of daily living, were unchanged.
Rebecca Wood, Chief Executive of the Alzheimer’s Research Trust, said:
“It’s very early days, but this study does suggest that this multinutrient drink is worthy of further investigation to help people with mild Alzheimer’s. Some nutrients are being investigated separately to see if they can benefit people with Alzheimer’s. The Alzheimer’s Research Trust is currently supporting work looking at the effects of B vitamins, found in dairy products, and omega-3 fatty acids, found in oily fish, on Alzheimer’s disease.
“We know that lifestyle, including diet, has a role to play in Alzheimer’s. The best evidence is that living a healthy lifestyle including a good diet and exercise can help lower the risk of Alzheimer’s, and it’s possible that these factors could also affect the disease itself.
“700,000 people in the UK have dementia, a number forecast to double in a generation. We need to invest in research now to offer hope of the future.”
Posted in Archive